The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2019

Filed:

Aug. 13, 2014
Applicant:

Epitomics, Inc., Cambridge, GB;

Inventors:

Mark Bushfield, Cambridge, GB;

Michael Hadjisavas, Foster City, CA (US);

Luc Adam, Hayward, CA (US);

Assignee:

EPITOMICS, INC., Burlingame, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); G01N 33/53 (2006.01); C12N 15/10 (2006.01); G16B 30/00 (2019.01); G16B 35/00 (2019.01); G16C 20/60 (2019.01); C07K 16/00 (2006.01); G01N 33/68 (2006.01); C07K 16/32 (2006.01); C07K 16/46 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1089 (2013.01); C07K 16/00 (2013.01); C07K 16/32 (2013.01); C07K 16/46 (2013.01); C12P 21/005 (2013.01); G01N 33/6854 (2013.01); G16B 30/00 (2019.02); G16B 35/00 (2019.02); G16C 20/60 (2019.02); C07K 2317/10 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract

A method of screening is provided. In certain embodiments, the method involves a) obtaining the nucleotide sequences of: i. a heavy chain-encoding nucleic acid that encodes the variable domain of a heavy chain of a first antibody of an animal; and ii. a light chain-encoding nucleic acid that encodes the variable domain of a light chain of the first antibody; b) obtaining nucleotide sequences of cDNAs encoding at least a portion of the antibody repertoire of the animal; c) computationally screening the sequences obtained in b) to identify heavy and light chain sequences that are related by lineage to the heavy and light chain sequences of a); and d) testing at least one pair of the heavy and light chain sequences identified in c) to identify a second antibody that binds to the same antigen as the first antibody.


Find Patent Forward Citations

Loading…